Showing results (21-30 of 642) with videos related to
Sort By:
Pageof 65
Journal of Enzyme Inhibition and Medicinal Chemistry|March 22, 2007
A quantitative structure-activity relationship study on matrix metalloproteinase inhibitors: piperidine sulfonamide aryl hydroxamic acid analogsS Kumaran, S P GuptaBioorganic & Medicinal Chemistry|January 9, 2003
A quantitative structure-activity relationship study on some matrix metalloproteinase and collagenase inhibitorsDalip Kumar, S P GuptaBioorganic & Medicinal Chemistry|June 24, 2003
A quantitative structure-activity relationship study on Clostridium histolyticum collagenase inhibitors: roles of electrotopological state indicesS P Gupta, S KumaranJournal of Enzyme Inhibition|April 1, 1997
Quantitative structure-activity relationship studies on some anti-human-immunodeficiency-virus-1 (anti-HIV-1) drugs: viral reverse transcriptase inhibitorsR Garg, S P GuptaJournal of Medical Engineering & Technology|April 3, 2009
A practical approach to designing operating instructions for medical products in late or post-design phasesS P Gupta, M LyonsBioorganic & Medicinal Chemistry|July 5, 2005
A quantitative structure-activity relationship study on some series of anthranilic acid-based matrix metalloproteinase inhibitorsS P Gupta, S KumaranIndian Journal of Biochemistry & Biophysics|June 1, 1993
Quantitative structure-activity relationship studies on benzodiazepine receptor binding: investigation of interaction modelS P Gupta, V MulchandaniDNA and Cell Biology|December 1, 1996
Xenopus cytochrome b561: molecular confirmation of a general five transmembrane structure and developmental regulation at the gastrula stageM SrivastavaBioorganic & Medicinal Chemistry|January 9, 1999
Quantitative structure-activity relationship studies on some nonbenzodiazepine series of compounds acting at the benzodiazepine receptorS P Gupta, A PaletiJournal of Enzyme Inhibition|January 1, 1997
Quantitative structure-activity relationship studies on some viral reverse transcriptase inhibitors acting as anti-HIV-1 agentsR Garg, S P GuptaPageof 65